Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Serum lipocalin-2 levels are increased in patients with psoriasis.

Kamata M, Tada Y, Tatsuta A, Kawashima T, Shibata S, Mitsui H, Asano Y, Sugaya M, Kadono T, Kanda N, Watanabe S, Sato S.

Clin Exp Dermatol. 2012 Apr;37(3):296-9. doi: 10.1111/j.1365-2230.2011.04265.x. Epub 2012 Feb 2.

PMID:
22300286
2.

Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome.

El-Hadidi H, Samir N, Shaker OG, Otb S.

Arch Dermatol Res. 2014 Apr;306(3):239-45. doi: 10.1007/s00403-013-1414-x. Epub 2013 Sep 20.

PMID:
24052155
3.

Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.

Stallhofer J, Friedrich M, Konrad-Zerna A, Wetzke M, Lohse P, Glas J, Tillack-Schreiber C, Schnitzler F, Beigel F, Brand S.

Inflamm Bowel Dis. 2015 Oct;21(10):2327-40. doi: 10.1097/MIB.0000000000000515.

PMID:
26263469
4.

Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.

Romaní J, Caixàs A, Ceperuelo-Mallafré V, Carrascosa JM, Ribera M, Rigla M, Vendrell J, Luelmo J.

Arch Dermatol Res. 2013 Mar;305(2):105-12. doi: 10.1007/s00403-012-1306-5. Epub 2012 Dec 16.

PMID:
23242471
5.

Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.

Wang XR, Li YP, Gao S, Xia W, Gao K, Kong QH, Qi H, Wu L, Zhang J, Qu JM, Bai CX.

Int J Chron Obstruct Pulmon Dis. 2014 May 27;9:543-9. doi: 10.2147/COPD.S62700. eCollection 2014.

6.

Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.

Ataseven A, Kesli R, Kurtipek GS, Ozturk P.

Dis Markers. 2014;2014:541709. doi: 10.1155/2014/541709. Epub 2014 Apr 2.

7.

The role of lipocalin-2 in liver regeneration.

Kienzl-Wagner K, Moschen AR, Geiger S, Bichler A, Aigner F, Brandacher G, Pratschke J, Tilg H.

Liver Int. 2015 Apr;35(4):1195-202. doi: 10.1111/liv.12634. Epub 2014 Jul 25.

PMID:
25040147
8.

Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome.

Ni J, Ma X, Zhou M, Pan X, Tang J, Hao Y, Lu Z, Gao M, Bao Y, Jia W.

Cardiovasc Diabetol. 2013 Dec 21;12:176. doi: 10.1186/1475-2840-12-176.

9.

Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?

Yigit IP, Celiker H, Dogukan A, Ilhan N, Gurel A, Ulu R, Aygen B.

Ren Fail. 2015 Feb;37(1):77-82. doi: 10.3109/0886022X.2014.975133. Epub 2014 Oct 27.

PMID:
25347233
10.

Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Behçet's disease.

Gul FC, Cicek D, Kaman D, Demir B, Nazik H.

Eur J Dermatol. 2015 Apr;25(2):195-7. doi: 10.1684/ejd.2014.2490. No abstract available.

PMID:
25547333
11.
12.

Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G.

J Mol Med (Berl). 2009 Aug;87(8):803-13. doi: 10.1007/s00109-009-0486-8. Epub 2009 May 23.

PMID:
19466389
13.

NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure.

Naudé PJ, Mommersteeg PM, Gouweleeuw L, Eisel UL, Denollet J, Westerhuis LW, Schoemaker RG.

World J Biol Psychiatry. 2015 Oct;16(7):536-41. doi: 10.3109/15622975.2015.1062550. Epub 2015 Jul 27.

PMID:
26212793
14.

The relationship between subclinical cardiovascular disease and lipocalin-2 levels in women with PCOS.

Gencer M, Gazi E, Hacıvelioğlu S, Binnetoğlu E, Barutçu A, Türkön H, Temiz A, Altun B, Vural A, Cevizci S, Kumcular T, Coşar E.

Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:99-103. doi: 10.1016/j.ejogrb.2014.07.032. Epub 2014 Aug 1.

PMID:
25145761
15.

Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease.

Oberoi R, Bogalle EP, Matthes LA, Schuett H, Koch AK, Grote K, Schieffer B, Schuett J, Luchtefeld M.

PLoS One. 2015 Sep 14;10(9):e0137924. doi: 10.1371/journal.pone.0137924. eCollection 2015.

16.

Increased plasma levels of lipocalin 2 in mild cognitive impairment.

Choi J, Lee HW, Suk K.

J Neurol Sci. 2011 Jun 15;305(1-2):28-33. doi: 10.1016/j.jns.2011.03.023. Epub 2011 Apr 3.

PMID:
21463871
17.

Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.

Antiga E, Quaglino P, Volpi W, Pierini I, Del Bianco E, Bianchi B, Novelli M, Savoia P, Bernengo MG, Fabbri P, Caproni M.

J Eur Acad Dermatol Venereol. 2014 Feb;28(2):222-30. doi: 10.1111/jdv.12091. Epub 2013 Jan 18.

18.

Cytokine elevation and transaminitis after laparoscopic donor nephrectomy.

Yap S, Park SW, Egan B, Lee HT.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1104-11. doi: 10.1152/ajprenal.00543.2011. Epub 2012 Jan 18.

19.

Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort.

Wu G, Li H, Fang Q, Jiang S, Zhang L, Zhang J, Hou X, Lu J, Bao Y, Xu A, Jia W.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2457-64. doi: 10.1161/ATVBAHA.114.303718. Epub 2014 Sep 4.

20.

Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.

Yeh YH, Chang JL, Hsiao PC, Tsao SM, Lin CH, Kao SJ, Chou MC, Yang SF, Chien MH.

J Clin Lab Anal. 2013 Jul;27(4):253-60. doi: 10.1002/jcla.21588.

PMID:
23852780

Supplemental Content

Support Center